[ASAP] Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters 🔗 Access full article via Journal of the American Chemical SocietyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
